{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:09:30Z","timestamp":1787738970603,"version":"build-2784847793"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013130","name":"Mundipharma Korea Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Western Pacific"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.lanwpc.2021.100126","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T06:07:00Z","timestamp":1616479620000},"page":"100126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Comprehensive analysis of peripheral T-cell and natural killer\/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia"],"prefix":"10.1016","volume":"10","author":[{"given":"Sang Eun","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dok Hyun","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsai-Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngil","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Won","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Sup","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin Kuang Wei","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon Thye","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosphiadi","family":"Irawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Rok","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark Hong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Chin","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won-Sik","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Jin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwan Jung","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryl Tan Chen","family":"Lung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Yong","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6357-7347","authenticated-orcid":false,"given":"Jae Joon","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeung-Chul","family":"Mun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Yong","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeok","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hye","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeong Seok","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Kyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Cheol","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Hyeh","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Seog","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.lanwpc.2021.100126_bib0001","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the international lymphoma study group classification of non-Hodgkin's lymphoma. The non-Hodgkin's lymphoma classification project","volume":"89","year":"1997","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.lanwpc.2021.100126_bib0002","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/bjc.2015.94","article-title":"Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network","volume":"112","author":"Smith","year":"2015","journal-title":"Br J Cancer"},{"issue":"S2","key":"10.1016\/j.lanwpc.2021.100126_bib0003","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hon.122_2629","article-title":"The T cell project 2.0: the more we register, the more we learn","volume":"37","author":"Federico","year":"2019","journal-title":"Hematol Oncol"},{"issue":"20","key":"10.1016\/j.lanwpc.2021.100126_bib0004","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.lanwpc.2021.100126_bib0005","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1182\/blood-2005-03-1306","article-title":"T-cell non-Hodgkin lymphoma","volume":"107","author":"Rizvi","year":"2006","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.lanwpc.2021.100126_bib0006","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1046\/j.1440-1827.2000.01108.x","article-title":"The world health organization classification of malignant lymphomas in Japan: Incidence of recently recognized entities","volume":"50","author":"Pathologists","year":"2000","journal-title":"Pathol Int"},{"issue":"3","key":"10.1016\/j.lanwpc.2021.100126_bib0007","first-page":"254","article-title":"WHO classification of malignant lymphomas in Korea: report of the third nationwide study","volume":"45","author":"Kim","year":"2011","journal-title":"J Pathol Transl Med"},{"issue":"11","key":"10.1016\/j.lanwpc.2021.100126_bib0008","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1002\/cam4.3037","article-title":"Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades","volume":"9","author":"Liu","year":"2020","journal-title":"Cancer Med"},{"issue":"25","key":"10.1016\/j.lanwpc.2021.100126_bib0009","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.lanwpc.2021.100126_bib0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2559.2010.03704.x","article-title":"Pathology and biology of peripheral T-cell lymphomas","volume":"58","author":"de Leval","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.lanwpc.2021.100126_bib0011","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1038\/bcj.2014.34","article-title":"The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomas","volume":"4","author":"Briski","year":"2014","journal-title":"Blood Cancer J"},{"issue":"10","key":"10.1016\/j.lanwpc.2021.100126_bib0012","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2014-04-573089","article-title":"Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish lymphoma registry","volume":"124","author":"Ellin","year":"2014","journal-title":"Blood"},{"issue":"33","key":"10.1016\/j.lanwpc.2021.100126_bib0013","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2011.35.6287","article-title":"Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)\/T-cell lymphoma, nasal type: the NK-cell tumor study group study","volume":"29","author":"Yamaguchi","year":"2011","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.lanwpc.2021.100126_bib0014","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2012-05-431460","article-title":"SMILE for natural killer\/T-cell lymphoma: analysis of safety and efficacy from the Asia lymphoma study group","volume":"120","author":"Kwong","year":"2012","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.lanwpc.2021.100126_bib0015","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1200\/JCO.2012.44.7524","article-title":"Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors","volume":"31","author":"Mak","year":"2013","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.lanwpc.2021.100126_bib0016","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1093\/annonc\/mdx316","article-title":"Beyond first-line non-anthracycline-based chemotherapy for extranodal NK\/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first relapse and progression of disease","volume":"28","author":"Lim","year":"2017","journal-title":"Ann Oncol"},{"issue":"19","key":"10.1016\/j.lanwpc.2021.100126_bib0017","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.lanwpc.2021.100126_bib0018","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin's lymphoma","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.lanwpc.2021.100126_bib0019","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","article-title":"Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study","volume":"103","author":"Gallamini","year":"2004","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.lanwpc.2021.100126_bib0020","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","article-title":"Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score","volume":"24","author":"Went","year":"2006","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.lanwpc.2021.100126_bib0021","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V106.11.811.811","article-title":"International peripheral T-cell lymphoma (PTCL) clinical and pathologic review project: poor outcome by prognostic indices and lack of efficacy with anthracyclines","volume":"106","author":"Vose","year":"2005","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.lanwpc.2021.100126_bib0022","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1470-2045(15)00533-1","article-title":"A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis","volume":"17","author":"Kim","year":"2016","journal-title":"Lancet Oncol"},{"issue":"27","key":"10.1016\/j.lanwpc.2021.100126_bib0023","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of hodgkin and non-Hodgkin lymphoma: the lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.lanwpc.2021.100126_bib0024","doi-asserted-by":"crossref","first-page":"e284","DOI":"10.1016\/S2352-3026(19)30283-2","article-title":"Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project","volume":"7","author":"Fox","year":"2020","journal-title":"Lancet Haematol"},{"issue":"17","key":"10.1016\/j.lanwpc.2021.100126_bib0025","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1182\/blood-2016-12-756841","article-title":"PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK\/T-cell lymphoma failing l-asparaginase","volume":"129","author":"Kwong","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.lanwpc.2021.100126_bib0026","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-018-0559-7","article-title":"Activity of pembrolizumab in relapsed\/refractory NK\/T-cell lymphoma","volume":"11","author":"Li","year":"2018","journal-title":"J Hematol Oncol"},{"issue":"17","key":"10.1016\/j.lanwpc.2021.100126_bib0027","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1182\/blood-2016-12-756841","article-title":"PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK\/T-cell lymphoma failing l-asparaginase","volume":"129","author":"Kwong","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.lanwpc.2021.100126_bib0028","article-title":"Avelumab for the treatment of relapsed or refractory extranodal NK\/T-cell lymphoma: an open-label phase 2 study","author":"Kim","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.lanwpc.2021.100126_bib0029","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-019-0717-6","article-title":"Pathogenesis and biomarkers of natural killer T cell lymphoma (NKTL)","volume":"12","author":"Somasundaram","year":"2019","journal-title":"J Hematol Oncol"},{"issue":"3","key":"10.1016\/j.lanwpc.2021.100126_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2020.02.005","article-title":"Genomic and transcriptomic characterization of natural killer T cell lymphoma","volume":"37","author":"Xiong","year":"2020","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.lanwpc.2021.100126_bib0031","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.3109\/10428190903186502","article-title":"Extranodal natural killer\/T-cell lymphoma: current concepts in biology and treatment","volume":"50","author":"Kohrt","year":"2009","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"10.1016\/j.lanwpc.2021.100126_bib0032","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/annonc\/mdh392","article-title":"Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification","volume":"15","author":"Savage","year":"2004","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.lanwpc.2021.100126_bib0033","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00280-018-3744-z","article-title":"A retrospective study of the CHOP, CHOPE, and CHOPE\/G regimens as the first-line treatment of peripheral T-cell lymphomas","volume":"83","author":"Liu","year":"2019","journal-title":"Cancer Chemother Pharmacol"},{"issue":"18","key":"10.1016\/j.lanwpc.2021.100126_bib0034","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1182\/blood-2010-02-270785","article-title":"Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German high-grade non-Hodgkin lymphoma study group","volume":"116","author":"Schmitz","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.lanwpc.2021.100126_bib0035","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1016\/S2352-3026(18)30039-5","article-title":"CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial","volume":"5","author":"Gleeson","year":"2018","journal-title":"Lancet Haematol"},{"issue":"10168","key":"10.1016\/j.lanwpc.2021.100126_bib0036","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(18)32984-2","article-title":"Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial","volume":"393","author":"Horwitz","year":"2019","journal-title":"Lancet North Am Ed"},{"issue":"25","key":"10.1016\/j.lanwpc.2021.100126_bib0037","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1200\/JCO.2011.40.2719","article-title":"Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01","volume":"30","author":"d'Amore","year":"2012","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.lanwpc.2021.100126_bib0038","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1200\/JCO.2008.17.4870","article-title":"Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study","volume":"27","author":"Reimer","year":"2009","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.lanwpc.2021.100126_bib0039","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.leu.2404306","article-title":"Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation","volume":"20","author":"Corradini","year":"2006","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.lanwpc.2021.100126_bib0040","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/cncr.31861","article-title":"The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: report from COMPLETE, a prospective, multicenter cohort study","volume":"125","author":"Park","year":"2019","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.lanwpc.2021.100126_bib0041","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-017-0030-y","article-title":"Outcomes of patients with peripheral T-cell lymphoma in first complete remission: data from three tertiary Asian cancer centers","volume":"7","author":"Tang","year":"2017","journal-title":"Blood Cancer J"},{"issue":"9","key":"10.1016\/j.lanwpc.2021.100126_bib0042","doi-asserted-by":"crossref","first-page":"867","DOI":"10.7150\/ijms.23067","article-title":"Outcome and prospective factor analysis of high-dose therapy combined with autologous peripheral blood stem cell transplantation in patients with peripheral T-cell lymphomas","volume":"15","author":"Wu","year":"2018","journal-title":"Int J Med Sci"},{"issue":"3","key":"10.1016\/j.lanwpc.2021.100126_bib0043","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/annonc\/mdx787","article-title":"Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers","volume":"29","author":"Fossard","year":"2018","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.lanwpc.2021.100126_bib0044","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-017-0030-y","article-title":"Outcomes of patients with peripheral T-cell lymphoma in first complete remission: data from three tertiary Asian cancer centers","volume":"7","author":"Tang","year":"2017","journal-title":"Blood Cancer J"},{"issue":"1","key":"10.1016\/j.lanwpc.2021.100126_bib0045","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5581\/1516-8484.20120013","article-title":"T-cell lymphomas in South america and europe","volume":"34","author":"Bellei","year":"2012","journal-title":"Revista brasileira de hematologia e hemoterapia"}],"container-title":["The Lancet Regional Health - Western Pacific"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606521000353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606521000353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:35:01Z","timestamp":1763001301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666606521000353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":45,"alternative-id":["S2666606521000353"],"URL":"https:\/\/doi.org\/10.1016\/j.lanwpc.2021.100126","relation":{},"ISSN":["2666-6065"],"issn-type":[{"value":"2666-6065","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive analysis of peripheral T-cell and natural killer\/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Western Pacific","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2021.100126","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Samsung Medical Center. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100126"}}